VIPL Antibodies

Santa Cruz Biotechnology delivers a wide array of VIPL monoclonal antibodies for research focused on Vasoactive Intestinal Peptide Receptor 1 (VIPR1) and its associated pathways. VIPL monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VIPR1 mediates the effects of vasoactive intestinal peptide, playing a significant role in regulating smooth muscle contraction, neurotransmission, and immune responses. Understanding VIPR1 function is essential for elucidating its involvement in various physiological processes and potential implications in diseases such as asthma and inflammatory bowel disease. Researchers investigating VIPR1 can utilize specific monoclonal antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC) for enhanced detection flexibility. VIPR1 research has revealed important insights into cellular signaling mechanisms and potential therapeutic targets. Advanced research techniques using VIPL monoclonal antibodies have uncovered new aspects of VIPR1's role in maintaining cellular homeostasis. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of VIPR1's role in human health and disease.